Filing Flows › GE HealthCare Technologies (GEHC) › Q3 2026 › vs Q2 2026
GE HealthCare Technologies (GEHC) Q3 2026 vs Q2 2026 (quarter over quarter)
GE HealthCare Technologies's revenue rose $218M (+4%) from $5.3B in Q2 2026 to $5.5B in Q3 2026. The biggest changes: Product +$186M (+5%); Service +$33.0M (+2%). Gross margin 40.3% against 41.2% (-0.8 pts).
GE HealthCare Technologies, Q3 2026: revenue $5.5B (+7% year over year), operating margin 14.6%, net earnings $615M, operating cash flow $907M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 40.3% | 41.2% | -0.8 pts |
| Operating margin | 14.6% | 14.0% | +0.6 pts |
| Net margin | 11.2% | 10.6% | +0.6 pts |
| Free cash flow margin | 14.4% | 1.3% | +13.1 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Product | $3.6B | $3.4B | $186M | +5% |
| Service | $1.9B | $1.9B | $33.0M | +2% |
| Revenue | $5.5B | $5.3B | $218M | +4% |
| Gross profit | $2.2B | $2.2B | $44.0M | +2% |
| Cost of revenue | $3.3B | $3.1B | $174M | +6% |
| Operating profit | $805M | $739M | $66.0M | +9% |
| Operating expenses | $1.4B | $1.4B | −$22.0M | -2% |
| Pre-tax earnings | $752M | $693M | $59.0M | +9% |
| Other expense, net | $53.0M | $46.0M | $7.0M | +15% |
| Research & development | $320M | $323M | −$3.0M | -0.9% |
| SG&A | $1.1B | $1.1B | −$18.0M | -2% |
| Net earnings | $615M | $561M | $54.0M | +10% |
| Minority interests | $8.0M | $12.0M | −$4.0M | -33% |
| Income tax | $129M | $119M | $10.0M | +8% |
| Depreciation & amortization | $163M | $160M | $3.0M | +2% |
| Share-based compensation | $36.0M | $45.0M | −$9.0M | -20% |
| Working capital & other | $93.0M | −$598M | $691M | — |
| Operating cash flow | $907M | $168M | $739M | +440% |
| Free cash flow (OCF − capex) | $793M | $68.0M | $725M | 12× |
| Capital expenditures | $114M | $100M | $14.0M | +14% |
Questions
How much did GE HealthCare Technologies's revenue grow quarter over quarter in Q3 2026?
GE HealthCare Technologies's revenue rose $218M (+4%) from $5.3B in Q2 2026 to $5.5B in Q3 2026.
What drove GE HealthCare Technologies's revenue change in Q3 2026?
Product +$186M (+5%); Service +$33.0M (+2%).